Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo

Peptide encyclopedia · Growth hormone secretagogue research

Ipamorelin comparison

Growth hormone secretagogue peptide (GHRP-class) · Full compound profile

Also see the expanded Ipamorelin compound database page with filters, related articles, and catalog links.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.

Ipamorelin is a Growth hormone secretagogue peptide (GHRP-class). It is not CJC-1295 or Retatrutide. This page separates those catalogue records. It is not stacking advice and not a protocol.

Ipamorelin
Growth hormone secretagogue peptide (GHRP-class)
Not the same record as
CJC-1295, Retatrutide
What decides the vial
Name, nominal fill, and lot number

Ipamorelin on its own record

Ipamorelin is a synthetic pentapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), the same receptor targeted by the endogenous hormone ghrelin. Its defining characteristic in the literature is selectivity relative to earlier secretagogues. VaultLabs supplies ipamorelin as a reference material for in vitro laboratory research only.

Chemical name: Ipamorelin.

Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2.

Receptor target: Growth hormone secretagogue receptor (GHS-R1a).

Structural class: Synthetic pentapeptide with non-standard residues.

Ipamorelin 5mg is the 5 mg lyophilized unit, listed at AED 299 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light. CJC-1295 (no DAC) 5mg + Ipamorelin 5mg is the 5 mg + 5 mg lyophilized unit, listed at AED 399 before VAT. The product record stores that sealed unit at 2–8 °C.

How Ipamorelin differs from the linked records

Ipamorelin versus CJC-1295. Ipamorelin is catalogued as a Growth hormone secretagogue peptide (GHRP-class). CJC-1295 is catalogued as a GHRH analog peptide (Growth hormone secretagogue research). They are separate records. No CAS for CJC-1295 is copied onto this page. A certificate for CJC-1295 does not qualify a Ipamorelin vial, and the reverse is also true. Read CJC-1295 on its own monograph rather than inferring it from this page.

Ipamorelin versus Retatrutide. Ipamorelin is catalogued as a Growth hormone secretagogue peptide (GHRP-class). Retatrutide is catalogued as a Multi-receptor agonist peptide (research literature) (Metabolic pathway research). They are separate records. Retatrutide is listed with CAS 2381089-83-2. A certificate for Retatrutide does not qualify a Ipamorelin vial, and the reverse is also true. Read Retatrutide on its own monograph rather than inferring it from this page.

Certificates do not cross over

Lot 238930 for CJC-1295 (no DAC) 5mg + Ipamorelin 5mg is a Janoshik Analytical report. The published record states Content reported. Figures printed on the report: Ipamorelin 4.83 mg; CJC-1295 (mod GRF 1-29) 4.68 mg. Method line on that report: CJC No DAC - MOD GRF (1-29)/Ipamorelin blend analysis. The laboratory file is linked from the certificate page. Open CJC-1295 (no DAC) 5mg + Ipamorelin 5mg certificate or match lot 238930 in batch verification. That report qualifies this lot only.

Lot VL-CJCIPA-20260321 is the catalogue certificate for CJC-1295 (no DAC) 5mg + Ipamorelin 5mg. Read it on CJC-1295 (no DAC) 5mg + Ipamorelin 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

Lot VL-IPA-20260917 is the catalogue certificate for Ipamorelin 5mg. Read it on Ipamorelin 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

Ipamorelin has both a laboratory report and catalogue certificates. Janoshik Analytical lot 238930 is the third-party file. The other lot numbers are catalogue certificates for their own fills. Match the printed lot. Do not treat one purity line as the result for every vial.

If a purchase order says Ipamorelin, a vial of a related compound does not satisfy it. If the order names a strength, a different strength of Ipamorelin does not satisfy it either.

What this comparison refuses to do

It does not rank Ipamorelin against another material, recommend a combination, or translate a paper into a dose. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Prices and the literature notes are on the Ipamorelin research summary. Sealed-unit handling is the Ipamorelin storage guide. The Ipamorelin compound monograph remains the long record.

VaultLabs dispatches Ipamorelin from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Questions this page answers

Is Ipamorelin the same material as CJC-1295?

No. Ipamorelin is a Growth hormone secretagogue peptide (GHRP-class). CJC-1295 is a separate catalogue record. Use the monograph for each one.

Can a blend certificate stand in for Ipamorelin?

No. A blend that contains Ipamorelin, or a similarly named component, has its own lot. That document does not release a single-sequence Ipamorelin vial, and a Ipamorelin certificate does not release the blend.

Related compounds

Research tools

Catalog products

Next recommended reading

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.